Expertise in
6
conditions

Olivier Huillard

Paris, FR 
Expertise in
6
conditions
Paris, FR 

Overview

Olivier Huillard practices practicing medicine in Paris, France.

Mr. Huillard is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Muscle Atrophy, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostate Cancer, and Cystectomy.

He is actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Paris, France
Other Locations
Clichy-sous-bois, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 01, 2026
Intervention Type: Drug
Study Drugs: Sacituzumab govitecan, Sacituzumab govitecan+Pembrolizumab, IMMU-132+Cisplatin, IMMU-132+Cisplatin+Avelumab
Study Phase: Phase 2

93 Total Publications

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 26, 2026

Frequently Asked Questions about Olivier Huillard

Is Olivier Huillard a top-rated expert for Muscle Atrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Olivier Huillard is classified as an Advanced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Olivier Huillard participate in research or clinical trials?

Yes. Olivier Huillard has published 93 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Olivier Huillard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Huillard's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile